Pfizer Financials - Benzinga

Pfizer Inc

PFENYSE

Trade with Public

Trade with Public

$27.74

0.080.29%

가까이에: Sep 21, 5:00 PM EST

$27.76

0.020.07%

시간외: 6:13 PM EST

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 배당금 비교 옵션 주식 보고서

Pfizer Financials

Pfizer (PFE) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Dow Jumps Over 900 Points As Crude Oil Falls: Investor Sentiment Improves Further, Fear Index Moves To ‘Greed’ Zone

Market sentiment improves, Dow Jones jumps 900 points to record high. Crude oil prices fall on potential deal to reopen Strait of Hormuz.

Avi Kapoor

Pfizer Says Monthly GLP-1 Candidate Could Rival Tirzepatide on Weight Loss

Pfizer stock rises after beating Q2 estimates and raising its 2026 revenue guidance to up to $62.5B. Get the key earnings takeaways.

Vandana Singh

Stock Market Today: S&P 500, Dow and Nasdaq Futures Gain as Scott Bessent Says Hormuz Deal Could Come Soon— Caterpiller, Palantir in Focus (UPDATED)

U.S. stock futures edged higher on Tuesday, with Dow, S&P 500 and Nasdaq 100 futures advancing after Wall Street's broad rally on Monday.

Eva Mathew

PRO
Pfizer Q2 Adj. EPS $0.77 Beats $0.69 Estimate, Sales $15.034B Beat $14.412B Estimate

Pfizer (NYSE:PFE) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.69 by 11.59 percent. This is a 1.28 percent decrease over earnings of $0.78 per share from the same period

Benzinga Newsdesk

PRO
Pfizer Affirms FY2026 Adj EPS Guidance of $2.80-$3.00 vs $2.95 Est; Raises FY2026 Sales Guidance from $59.500B-$62.500B to $60.500B-$62.500B vs $61.793B Est

Pfizer (NYSE:PFE) affirms FY2026 Adj EPS guidance from $2.80-$3.00 to $2.80-$3.00 vs $2.95 analyst estimate. Raises FY2026 sales outlook from $59.500 billion-$62.500 billion to $60.500 billion-$62.500 billion vs $61.793

Benzinga Newsdesk

Dow Closes at Record High, Nasdaq Surges 2%, but Fear & Greed Index Signals Investors Are Still Playing It Safe

Fear & Greed Index improves, Dow Jones hits record high, oil prices fall after Trump's Iran decision. CNH & Makemytrip stocks gain on earnings.

Avi Kapoor

© 2026 Benzinga | All Rights Reserved